 Adrenergic beta-2 Receptor Agonists
"Adrenergic beta-2 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.
| Descriptor ID |
D058666
|
| MeSH Number(s) |
D27.505.519.625.050.100.200.200 D27.505.696.577.050.100.200.200
|
| Concept/Terms |
Adrenergic beta-2 Receptor Agonists- Adrenergic beta-2 Receptor Agonists
- Adrenergic beta 2 Receptor Agonists
- Adrenergic beta2-Agonists
- Adrenergic beta2 Agonists
- beta2-Agonists, Adrenergic
- Adrenergic beta-2 Agonists
- Adrenergic beta 2 Agonists
- Agonists, Adrenergic beta-2
- beta-2 Agonists, Adrenergic
- Adrenergic beta-2 Receptor Agonist
- Adrenergic beta 2 Receptor Agonist
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-2 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-2 Receptor Agonists".
This graph shows the total number of publications written about "Adrenergic beta-2 Receptor Agonists" by people in UAMS Profiles by year, and whether "Adrenergic beta-2 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2025 | 2 | 0 | 2 | | 2020 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic beta-2 Receptor Agonists" by people in Profiles over the past ten years.
-
Rayner DG, Bakaa L, Hoyte F, Perry TT, Rivera-Spoljaric K, Sumino K, Chipps B, Oppenheimer J, Nyenhuis SM, Israel E, McCabe E, O'Byrne PM, Shade LE, Press VG, Guyatt GH, Rangel S, Sue-Wah-Sing D, Hall L, Orr H, Melendez A, Winders T, Gardner DD, Przywara K, Rank MA, Bacharier LB, Mosnaim G, Chu DK. Triple therapy vs dual inhaler therapy for moderate-to-severe asthma: An updated systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2025 Sep; 135(3):278-286.e11.
-
Rayner DG, Ferri DM, Guyatt GH, O'Byrne PM, Brignardello-Petersen R, Foroutan F, Chipps B, Sumino K, Perry TT, Nyenhuis S, Oppenheimer J, Israel E, Hoyte F, Rivera-Spoljaric K, McCabe E, Rangel S, Shade LE, Press VG, Hall L, Sue-Wah-Sing D, Melendez A, Orr H, Winders T, Gardner DD, Przywara K, Rank MA, Bacharier LB, Mosnaim G, Chu DK. Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis. JAMA. 2025 01 14; 333(2):143-152.
-
Chen R, Zhong N, Wang HY, Zhao L, Mei X, Qin Z, Huang J, Assam PN, Maes A, Siddiqui S, Martin UJ, Reisner C. Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD. Int J Chron Obstruct Pulmon Dis. 2020; 15:43-56.
-
Arif E, Solanki AK, Srivastava P, Rahman B, Fitzgibbon WR, Deng P, Budisavljevic MN, Baicu CF, Zile MR, Megyesi J, Janech MG, Kwon SH, Collier J, Schnellmann RG, Nihalani D. Mitochondrial biogenesis induced by the ?2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury. Kidney Int. 2019 09; 96(3):656-673.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|